Donate to PCRI:
To ask a question privately, email info@pcri.org
Mark Scholz, MD and Joanne Weidhaas, MD, PhD, MSM, discuss new tests that can predict radiation toxicity and an update about COVID-19 testing. Dr. Wiedhass is a Professor of Radiation Oncology and Director the Division of Molecular and Cellular Oncology at the David Geffen School of Medicine at UCLA. She is the co-founder of MiraDx, a genomics testing company that has created COVID-19 assays and tests that can detect how likely radiation toxicity is to occur with radiation treatment. The interview will be followed by live Q+A with Dr. Scholz. He will be covering all questions about prostate cancer care, and men’s health. Visit PCRI.org to RSVP and submit your questions early.
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute’s YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #covid-19 #MarkScholzMD #Joanneweidhaasmd
